Every quarter, Locust Walk’s medtech team compiles the latest statistics and trends on strategic medtech transactions and financings, with a focus on upcoming trends.
Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing...
On September 6, 2019, Chris Ehrlich, Dartmouth College alumni and Locust Walk’s Managing Director, Global Head of Biopharma, will be speaking at the Dartmouth Entrepreneurs Forum in San Francisco. Chris will be moderating the Healthcare in 2030 panel, engaging...
I recently returned from a month in Europe as part of our effort to expand Locust Walk’s European practice. It was an amazing trip meeting great people and learning valuable lessons. While I did not visit all countries for business, I thought I’d share a...
